{ "responseHeader":{ "status":0, "QTime":0, "params":{ "q":"iati_identifier:GB-COH-03877777-F327601-01", "fl":"*", "format":"json" } }, "response":{ "numFound":1, "start":0, "numFoundExact":true, "docs":[{ "last-updated-datetime":"2025-06-27T07:25:23Z", "last_updated_datetime":"Fri Jun 27 07:25:23 UTC 2025", "last_updated_datetime_f":"2025-06-27T07:25:23Z", "lang":"en", "default_lang":"en", "default-currency":"USD", "default_currency":"USD", "humanitarian":false, "hierarchy":1, "iati-identifier":"GB-COH-03877777-F327601-01", "iati_identifier":"GB-COH-03877777-F327601-01", "reporting-org.type":"15", "reporting_org_type_code":"15", "reporting-org.ref":"GB-COH-03877777", "reporting_org_ref":"GB-COH-03877777", "reporting-org.secondary-reporter":false, "reporting_org_secondary_reporter":"0", "reporting-org.narrative":[" British International Investment plc"], "reporting_org_narrative":[" British International Investment plc"], "reporting-org.narrative.lang":["en"], "title.narrative":["mPharma Data Inc"], "title_narrative":["mPharma Data Inc"], "title_narrative_text":["mPharma Data Inc"], "title.narrative.lang":[" "], "title_narrative_lang":[" "], "description.type":["1","4"], "description_type":["1","4"], "description.narrative":["mPharma is a tech-enabled healthcare company developing a more-efficient supply chain for pharmaceutical products across Africa.","Equity"], "description_narrative":["mPharma is a tech-enabled healthcare company developing a more-efficient supply chain for pharmaceutical products across Africa.","Equity"], "description_narrative_text":["mPharma is a tech-enabled healthcare company developing a more-efficient supply chain for pharmaceutical products across Africa.","Equity"], "description.narrative.lang":[" "," "], "description_narrative_lang":[" "," "], "participating-org.ref":["GB-COH-03877777"], "participating_org_ref":["GB-COH-03877777"], "participating-org.type":["15"], "participating_org_type":["15"], "participating-org.role":["1"], "participating_org_role":["1"], "participating-org.narrative":["British International Investment plc"], "participating_org_narrative":["British International Investment plc"], "participating_org_narrative_text":["British International Investment plc"], "participating-org.narrative.lang":[" "], "participating_org_narrative_lang":[" "], "activity-status.code":"2", "activity_status_code":"2", "activity-date.type":["2","1"], "activity_date_type":["2","1"], "activity-date.iso-date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "activity_date_iso_date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "contact-info.type":["4"], "contact_info_type":["4"], "contact-info.organisation.narrative":["British International Investment plc"], "contact_info_organisation_narrative":["British International Investment plc"], "contact_info_organisation_narrative_text":["British International Investment plc"], "contact-info.organisation.narrative.lang":[" "], "contact_info_organisation_narrative_lang":[" "], "contact-info.department.narrative":["Communications Department"], "contact_info_department_narrative":["Communications Department"], "contact_info_department_narrative_text":["Communications Department"], "contact-info.department.narrative.lang":[" "], "contact_info_department_narrative_lang":[" "], "contact-info.telephone":["+44 20 7963 4700"], "contact_info_telephone":["+44 20 7963 4700"], "contact-info.email":["enquiries@bii.co.uk"], "contact_info_email":["enquiries@bii.co.uk"], "contact-info.website":["https://www.bii.co.uk"], "contact_info_website":["https://www.bii.co.uk"], "contact-info.mailing-address.narrative":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact_info_mailing_address_narrative_text":["BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom"], "contact-info.mailing-address.narrative.lang":[" "], "contact_info_mailing_address_narrative_lang":[" "], "recipient-country.code":["GH"], "recipient_country_code":["GH"], "recipient-country.percentage":[100.0], "recipient_country_percentage":[100.0], "sector.code":["351030"], "sector_code":["351030"], "sector.vocabulary":["99"], "sector_vocabulary":["99"], "sector.vocabulary-uri":["https://aidstream.org/reference/codelist/GB-COH-03877777/sector"], "sector_vocabulary_uri":["https://aidstream.org/reference/codelist/GB-COH-03877777/sector"], "sector.narrative":["Health Care Technology"], "sector_narrative":["Health Care Technology"], "sector_narrative_text":["Health Care Technology"], "sector.narrative.lang":[" "], "sector_narrative_lang":[" "], "collaboration-type.code":"6", "collaboration_type_code":"6", "default-flow-type.code":"10", "default_flow_type_code":"10", "default-aid-type.code":["C01"], "default_aid_type":["C01"], "default_aid_type_category_code":["C01"], "default_aid_type_code":["C01"], "default-aid-type.vocabulary":["1"], "default_aid_type_vocabulary":["1"], "default-tied-status.code":"5", "default_tied_status_code":"5", "transaction.transaction-type.code":["2","2","2","2","2"], "transaction_type":["2","2","2","2","2"], "transaction.transaction-date.iso-date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "transaction_date_iso_date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "transaction.value":[2054560.0,2054560.0,2054560.0,2054560.0,2054560.0], "transaction_value":[2054560.0,2054560.0,2054560.0,2054560.0,2054560.0], "transaction.description.narrative":["This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market."], "transaction_description_narrative":["This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.","This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market."], "transaction.description.narrative.lang":[" "," "," "," "," "], "transaction_description_lang":[" "," "," "," "," "], "transaction.provider-org.ref":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction_provider_org_ref":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction.provider-org.provider-activity-id":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction_provider_org_provider_activity_id":["GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777","GB-COH-03877777"], "transaction.provider-org.type":["70","70","70","70","70"], "transaction_provider_org_type":["70","70","70","70","70"], "transaction.provider-org.narrative":["British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc"], "transaction_provider_org_narrative":["British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc"], "transaction_provider_org_narrative_text":["British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc","British International Investment plc"], "transaction.provider-org.narrative.lang":[" "," "," "," "," "], "transaction_provider_org_narrative_lang":[" "," "," "," "," "], "transaction.receiver-org.narrative":["https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/"], "transaction_receiver_org_narrative":["https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/"], "transaction_receiver_org_narrative_text":["https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/","https://mpharma.com/"], "transaction.receiver-org.narrative.lang":[" "," "," "," "," "], "transaction_receiver_org_narrative_lang":[" "," "," "," "," "], "transaction.value.value-date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "transaction_value_date":["2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z","2020-03-20T00:00:00Z"], "document-link.url":["https://www.bii.co.uk/en/our-impact/investment/mpharma-data-inc-investment-01/"], "document_link_url":["https://www.bii.co.uk/en/our-impact/investment/mpharma-data-inc-investment-01/"], "document-link.format":["application/link-format"], "document_link_format":["application/link-format"], "document-link.title.narrative":["Quartely Report"], "document_link_title_narrative":["Quartely Report"], "document_link_title_narrative_text":["Quartely Report"], "document-link.title.narrative.lang":[" "], "document_link_title_narrative_lang":[" "], "document-link.category.code":["A12"], "document_link_category_code":["A12"], "document-link.language.code":["en"], "document_link_language_code":["en"], "document-link.document-date.iso-date":["2025-07-01T00:00:00Z"], "document_link_document_date_iso_date":["2025-07-01T00:00:00Z"], "reporting-org.type.name":"Other Public Sector", "reporting_org_type_name":"Other Public Sector", "recipient-country.name":["Ghana"], "recipient_country_name":["Ghana"], "default-aid-type.name":["Project-type interventions"], "default_aid_type_category_name":["Project-type interventions"], "title.narrative.first":"mPharma Data Inc", "title_narrative_first":"mPharma Data Inc", "activity-date.start-actual":"2020-03-20T00:00:00Z", "activity_date_start_actual":"Fri Mar 20 00:00:00 UTC 2020", "activity_date_start_actual_f":"2020-03-20T00:00:00Z", "activity-date.common.start":"2020-03-20T00:00:00Z", "activity_date_start_common":"Fri Mar 20 00:00:00 UTC 2020", "activity_date_start_common_f":"2020-03-20T00:00:00Z", "activity-date.start-planned":"2020-03-20T00:00:00Z", "activity_date_start_planned":"Fri Mar 20 00:00:00 UTC 2020", "activity_date_start_planned_f":"2020-03-20T00:00:00Z", "activity-status.text":"Implementation", "activity_status_text":"Implementation", "transaction.value-usd.sum":1.02728E7, "transaction_value_usd_sum":1.02728E7, "transaction.value-usd.conversion-rate":[1.0,1.0,1.0,1.0,1.0], "transaction_usd_conversion_rate":[1.0,1.0,1.0,1.0,1.0], "transaction.value-usd.conversion-currency":["USD"], "transaction.value-gbp.sum":8300919.255570084, "transaction_value_gbp_sum":8300919.255570084, "transaction.value-gbp.conversion-rate":[1.2375496838023987,1.2375496838023987,1.2375496838023987,1.2375496838023987,1.2375496838023987], "transaction_gbp_conversion_rate":[1.2375496838023987,1.2375496838023987,1.2375496838023987,1.2375496838023987,1.2375496838023987], "transaction.value-gbp.conversion-currency":["USD"], "dataset.id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset_iati_id":"7e4b5f6f-a12c-4a85-b555-e63f75af07b5", "dataset.name":"bii-activities", "dataset_name":"bii-activities", "dataset.extras.iati_version":"2.03", "dataset.resources.hash":"45892ebb68e2a1f3ed94b9d52c4bb262558a46e3", "dataset.resources.url":"https://aidstream.s3.us-west-2.amazonaws.com/xml/bii-activities.xml", "activity-date.quarter":[1,1], "transaction.transaction-date.quarter":[1,1,1,1,1], "document-link.document-date.quarter":[3], "document-link.category-codes-combined":["A12"], "transaction.value-usd":[2054560.0,2054560.0,2054560.0,2054560.0,2054560.0], "transaction_value_usd":[2054560.0,2054560.0,2054560.0,2054560.0,2054560.0], "transaction.value-usd-type":[2,2,2,2,2], "transaction.value-gbp":[1660183.8511140167,1660183.8511140167,1660183.8511140167,1660183.8511140167,1660183.8511140167], "transaction_value_gbp":[1660183.8511140167,1660183.8511140167,1660183.8511140167,1660183.8511140167,1660183.8511140167], "transaction.value-gbp-type":[2,2,2,2,2], "activity-aggregation.outgoing-commitment.value":1.02728E7, "activity_aggregation_commitment_value":1.02728E7, "activity-aggregation.outgoing-commitment.value-usd":1.02728E7, "activity_aggregation_commitment_value_usd":1.02728E7, "activity-aggregation.outgoing-commitment.value-gbp":8300919.255570084, "activity_aggregation_commitment_value_gbp":8300919.255570084, "json.reporting-org":"{\"type\": 15, \"ref\": \"GB-COH-03877777\", \"secondary-reporter\": 0, \"narrative\": \" British International Investment plc\", \"narrative.lang\": \"en\"}", "json.title":"{\"narrative\": \"mPharma Data Inc\", \"narrative.lang\": \" \"}", "json.description":["{\"type\": 1, \"narrative\": \"mPharma is a tech-enabled healthcare company developing a more-efficient supply chain for pharmaceutical products across Africa.\", \"narrative.lang\": \" \"}","{\"type\": 4, \"narrative\": \"Equity\", \"narrative.lang\": \" \"}"], "json.participating-org":["{\"ref\": \"GB-COH-03877777\", \"type\": 15, \"role\": 1, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}"], "json.activity-date":["{\"type\": 2, \"iso-date\": \"2020-03-20\"}","{\"type\": 1, \"iso-date\": \"2020-03-20\"}"], "json.contact-info":["{\"type\": 4, \"organisation\": {\"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"department\": {\"narrative\": \"Communications Department\", \"narrative.lang\": \" \"}, \"telephone\": \"+44 20 7963 4700\", \"email\": \"enquiries@bii.co.uk\", \"website\": \"https://www.bii.co.uk\", \"mailing-address\": {\"narrative\": \"BII plc, 123 Victoria Street, London, SW1E 6DE, United Kingdom\", \"narrative.lang\": \" \"}}"], "json.recipient-country":["{\"code\": \"GH\", \"percentage\": 100}"], "json.sector":["{\"code\": 351030, \"vocabulary\": 99, \"vocabulary-uri\": \"https://aidstream.org/reference/codelist/GB-COH-03877777/sector\", \"narrative\": \"Health Care Technology\", \"narrative.lang\": \" \"}"], "json.default-aid-type":["{\"code\": \"C01\", \"vocabulary\": 1}"], "json.transaction":["{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-03-20\"}, \"value\": 2054560, \"description\": {\"narrative\": \"This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://mpharma.com/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2020-03-20\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-03-20\"}, \"value\": 2054560, \"description\": {\"narrative\": \"This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://mpharma.com/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2020-03-20\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-03-20\"}, \"value\": 2054560, \"description\": {\"narrative\": \"This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://mpharma.com/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2020-03-20\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-03-20\"}, \"value\": 2054560, \"description\": {\"narrative\": \"This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://mpharma.com/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2020-03-20\"}","{\"transaction-type\": {\"code\": 2}, \"transaction-date\": {\"iso-date\": \"2020-03-20\"}, \"value\": 2054560, \"description\": {\"narrative\": \"This investment is part of our 'VC Scale-up' strategy to support the growth of the most impactful companies in our venture capital funds portfolio. Our investment in mPharma supports the company's plan to transform the pharmaceutical value chain in Africa in order to improve affordability, accessibility and quality of medicines for the mass market.\", \"narrative.lang\": \" \"}, \"provider-org\": {\"ref\": \"GB-COH-03877777\", \"provider-activity-id\": \"GB-COH-03877777\", \"type\": 70, \"narrative\": \"British International Investment plc\", \"narrative.lang\": \" \"}, \"receiver-org\": {\"narrative\": \"https://mpharma.com/\", \"narrative.lang\": \" \"}, \"value.value-date\": \"2020-03-20\"}"], "json.document-link":["{\"url\": \"https://www.bii.co.uk/en/our-impact/investment/mpharma-data-inc-investment-01/\", \"format\": \"application/link-format\", \"title\": {\"narrative\": \"Quartely Report\", \"narrative.lang\": \" \"}, \"category\": [{\"code\": \"A12\"}], \"language\": {\"code\": \"en\"}, \"document-date\": [{\"iso-date\": \"2025-07-01\"}]}"], "id":"37516406-bd10-40a5-9092-7e02006956fe", "_version_":1863489638984843264 }] } }